Outcomes of corticosteroid therapy in patients with viral community-acquired pneumonia

Aim: The objective of this study was to assess the therapeutic effects of corticosteroids in adult patients hospitalized with viral community-acquired pneumonia. Methods: This is a retrospective analysis of data collected prospectively from November 1996 to June 2024. All adult patients with viral community-acquired pneumonia were enrolled. The primary outcome was 30-day mortality. Secondary outcomes included all-cause in-hospital mortality, ICU admission, length of ICU and hospital stay, mechanical ventilation, and 1-year mortality. Propensity score matching (PSM) was used to obtain balance among the baseline variables in the two groups. Results: Of the 524 patients with viral pneumonia, 30 (6%) received corticosteroids and 494 (94%) did not. Patients were primarily male (n = 299, 57%), with a median [Q1-Q3] age of 66.9 [55-81] years. The 3:1 propensity matching procedure identified 90 patients not treated with corticosteroid (CS-) as controls. After PSM, no difference in 30-day mortality was found [7% (95%CI 1 to 22%) vs. 4% (95%CI 1 to 11%), p = 0.639]. The risk of death at 30 days did not differ significantly in unmatched and matched cohorts [Hazard Ratio (HR) 1.33 (0.32-5.63), p = 0.695 vs. HR 1.51 (0.28-8.27), p = 0.632, respectively]. Nor were differences found in hospital length of stay, ICU admission and length of stay, or mechanical ventilation requirement and duration between matched and unmatched CS + and CS-. Conclusions: There were no significant differences in the primary and secondary outcomes regarding the use of corticosteroids in patients with viral pneumonia

From EHR to EDC - The Experience at the Policlinico Hospital in Milan.

n/

Early mobilisation in critically ill COVID-19 patients: a subanalysis of the ESICM-initiated UNITE-COVID observational study

Background Early mobilisation (EM) is an intervention that may improve the outcome of critically ill patients. There is limited data on EM in COVID-19 patients and its use during the first pandemic wave. Methods This is a pre-planned subanalysis of the ESICM UNITE-COVID, an international multicenter observational study involving critically ill COVID-19 patients in the ICU between February 15th and May 15th, 2020. We analysed variables associated with the initiation of EM (within 72 h of ICU admission) and explored the impact of EM on mortality, ICU and hospital length of stay, as well as discharge location. Statistical analyses were done using (generalised) linear mixed-effect models and ANOVAs. Results Mobilisation data from 4190 patients from 280 ICUs in 45 countries were analysed. 1114 (26.6%) of these patients received mobilisation within 72 h after ICU admission; 3076 (73.4%) did not. In our analysis of factors associated with EM, mechanical ventilation at admission (OR 0.29; 95% CI 0.25, 0.35; p = 0.001), higher age (OR 0.99; 95% CI 0.98, 1.00; p ≤ 0.001), pre-existing asthma (OR 0.84; 95% CI 0.73, 0.98; p = 0.028), and pre-existing kidney disease (OR 0.84; 95% CI 0.71, 0.99; p = 0.036) were negatively associated with the initiation of EM. EM was associated with a higher chance of being discharged home (OR 1.31; 95% CI 1.08, 1.58; p = 0.007) but was not associated with length of stay in ICU (adj. difference 0.91 days; 95% CI − 0.47, 1.37, p = 0.34) and hospital (adj. difference 1.4 days; 95% CI − 0.62, 2.35, p = 0.24) or mortality (OR 0.88; 95% CI 0.7, 1.09, p = 0.24) when adjusted for covariates. Conclusions Our findings demonstrate that a quarter of COVID-19 patients received EM. There was no association found between EM in COVID-19 patients' ICU and hospital length of stay or mortality. However, EM in COVID-19 patients was associated with increased odds of being discharged home rather than to a care facility. Trial registration ClinicalTrials.gov: NCT04836065 (retrospectively registered April 8th 2021)

Biomolecular Phenotyping Primary Graft Dysfunction after Lung Transplantation: a scoping review

Primary graft dysfunction (PGD) is the most common complication and leading cause of early mortality and long-term disability after lung transplantation (LUTX). PGD is an acute form of acute lung injury resulting from ischemia-reperfusion injury, with an incidence around 30%, defined and graded upon alteration of oxygenation and radiographic criteria occurring within 72 hours after graft reperfusion. Predictive enrichment by measurement of plasma biomarkers may allow for the detection of different treatable traits in patients who have undergone lung transplant (e.g., hypoinflammatory vs. hyperinflammatory) and thus apply further targeted treatments to these sub-cohorts. With this scoping review, we want to collate the literature regarding early plasmatic biomarkers of PGD in adult patients who have undergone double-lung transplantation

Outcomes of corticosteroid therapy in patients with viral community-acquired pneumonia

Abstract Aim The objective of this study was to assess the therapeutic effects of corticosteroids in adult patients hospitalized with viral community-acquired pneumonia. Methods This is a retrospective analysis of data collected prospectively from November 1996 to June 2024. All adult patients with viral community-acquired pneumonia were enrolled. The primary outcome was 30-day mortality. Secondary outcomes included all-cause in-hospital mortality, ICU admission, length of ICU and hospital stay, mechanical ventilation, and 1-year mortality. Propensity score matching (PSM) was used to obtain balance among the baseline variables in the two groups. Results Of the 524 patients with viral pneumonia, 30 (6%) received corticosteroids and 494 (94%) did not. Patients were primarily male (n = 299, 57%), with a median [Q1-Q3] age of 66.9 [55–81] years. The 3:1 propensity matching procedure identified 90 patients not treated with corticosteroid (CS-) as controls. After PSM, no difference in 30-day mortality was found [7% (95%CI 1 to 22%) vs. 4% (95%CI 1 to 11%), p = 0.639]. The risk of death at 30 days did not differ significantly in unmatched and matched cohorts [Hazard Ratio (HR) 1.33 (0.32–5.63), p = 0.695 vs. HR 1.51 (0.28–8.27), p = 0.632, respectively]. Nor were differences found in hospital length of stay, ICU admission and length of stay, or mechanical ventilation requirement and duration between matched and unmatched CS + and CS-. Conclusions There were no significant differences in the primary and secondary outcomes regarding the use of corticosteroids in patients with viral pneumonia

Biomolecular Phenotyping Primary Graft Dysfunction after Lung Transplantation: a scoping review

Primary graft dysfunction (PGD) is the most common complication and leading cause of early mortality and long-term disability after lung transplantation (LUTX). PGD is an acute form of acute lung injury resulting from ischemia-reperfusion injury, with an incidence around 30%, defined and graded upon alteration of oxygenation and radiographic criteria occurring within 72 hours after graft reperfusion. Predictive enrichment by measurement of plasma biomarkers may allow for the detection of different treatable traits in patients who have undergone lung transplant (e.g., hypoinflammatory vs. hyperinflammatory) and thus apply further targeted treatments to these sub-cohorts. With this scoping review, we want to collate the literature regarding early plasmatic biomarkers of PGD in adult patients who have undergone double-lung transplantation

A combined rapid clinical and lung ultrasound score for predicting bronchiolitis severity

Abstract Introduction Lung Ultrasound (LUS) has demonstrated good correlation with clinical severity scores in bronchiolitis but should be combined with clinical data to achieve best results. Aim of the study is to create a quick and reliable clinical-ultrasound score to predict the risk of Pediatric Intensive Care (Picu) admission as soon as the patient enters the Emergency Department (ED). Methods Retrospective study conducted at two pediatric EDs. Lung was divided into six zones and scanned with ultrasound; every zone received a score. Clinical data were obtained. For the outcomes “Picu admission”and “Cpap ventilation”, a multivariate analysis was conducted and the significant factors resulting were used to create a 3- items score to predict Picu admission. Area under the Receiver-Operating Curve (AUC) for specificity and sensibility of the score was obtained. Results 74 patients were enrolled; 34% were admitted to PICU. 31% were treated with CPAP. For the outcome “PICU admission”, multivariate analysis demonstrated presence of wheezing and reduced oral intake to be significant together with ultrasound involvement of the Right Posterior Upper Zone and Left Posterior Basal Zone. For the outcome “CPAP ventilation”, same clinical factors plus involvement of Right Posterior Upper Zone were significant. A 3-items score (1: presence of wheezing; 2: reduced oral intake; 3: LUS involvement of Right Posterior Upper Zone) for prediction of PICU admission was created which presents an AUC of 0.8249. Conclusions We were able to create a simple and quick score to predict need for PICU admission in bronchiolitis.</jats:p

Early serum biomarkers to characterise different phenotypes of primary graft dysfunction after lung transplantation: a systematic scoping review

Background Lung transplantation (LUTX) is often complicated by primary graft dysfunction (PGD). Plasma biomarkers hold potential for PGD phenotyping and targeted therapy. This scoping review aims to collect the available literature in search of serum biomarkers for PGD phenotyping. Methods Following JBI and PRISMA guidelines, we conducted a systematic review searching MEDLINE, Web of Science, EMBASE and The Cochrane Library for papers reporting the association between serum biomarkers measured within 72 h of reperfusion and PGD, following International Society for Heart and Lung Transplantation (ISHLT) guidelines. We extracted study details, patient demographics, PGD definition and timing, biomarker concentration, and their performance in identifying PGD cases. Results Among the 1050 papers screened, 25 prospective observational studies were included, with only nine conducted in the last decade. These papers included 1793 unique adult patients (1195 double LUTX, median study size 100 (IQR 44–119)). Most (n=21) compared PGD grade 3 to less severe PGD, but only four adhered to 2016 PGD definitions. Enzyme-linked immunosorbent assays and the multiplex bead array technique were utilised in 23 and two papers, respectively. In total, 26 candidate biomarkers were identified, comprising 13 inflammatory, three endothelial activation, three epithelial injury, three cellular damage and two coagulation dysregulation markers. Only five biomarkers (sRAGE, ICAM-1, PAI-1, SP-D, FSTL-1) underwent area under the receiver operating characteristic curve analysis, yielding a median value of 0.58 (0.51–0.78) in 406 patients (276 double LUTX). Conclusions Several biomarkers exhibit promise for future studies aimed at PGD phenotyping after LUTX. To uncover the significant existing knowledge gaps, further international prospective studies incorporating updated diagnostic criteria, modern platforms and advanced statistical approaches are essential